The prize is awarded to eminent scientists who have made outstanding contributions to neurochemistry and related subjects. Professor Eric Barnard from the Department of Pharmacology at University of Cambridge also receives the award for his contribution in making neurobiology the experimental discipline it is today.

Following his biochemical isolation and purification of nicotinic acetycholine receptor he was the first to clone the alpha-subunit of the GABA receptor – providing an understanding of the diseases of the central nervous system – and with that the major implications for pharmacology and medicine. Subsequently Eric turned his attention to G-protein-coupled receptors and was the first to clone a receptor for ATP. Professor Barnard has also identified the mouse muscular dystrophy (common autosomal recessive disorder) mfx gene mutation.

During Professor Barnard’s scientific tenure his laboratory has produced some of the Biochemical Society´s most successful younger neuroscientists, reflecting his true eminence in the field. He is still highly active in research, especially in the increasingly important ATP receptor field. He has, since 1999, been Distinguished Research Group Leader, funded by the Wellcome Trust, in the Department of Pharmacology at University of Cambridge. He is also Emeritus Professor of Neuroscience of the Royal Free and University College School of Medicine, London.

MEDICA.de; Source: The Biochemical Society